Currently, there are two pathways believed to promote tumor formation: the exogenous pathway, in which inflammation increases the risk of tumor formation, and the endogenous pathway, in which driver gene mutations such as JAK2, MPL, and CALR lead to the formation of an inflammatory microenvironment.2 This evidence concerns the gene JAK2 and neoplasm.